PCVX
Vaxcyte
$58.90
−$0.61 (−1.03%)Sep 10, 2026
Key metrics
The numbers that frame PCVX today
- Market cap
- $8.76B
- P/E (TTM)
- -8.2
- EV / FCF
- -9.4
- ROIC
- -37.8%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $30.81
- 52wk High
- $64.79
Growth
Revenue and earnings trend for PCVX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about PCVX
Is Vaxcyte a good buy?
Hold. Vaxcyte has excellent momentum, but poor quality makes the setup mixed. Growth looks weak. That could put pressure on the long-term business case. We think Vaxcyte is selling at a very high price.
What is the market capitalization of PCVX?
Vaxcyte's market capitalization is $8.76B.
What is the P/E ratio for PCVX stock?
Vaxcyte's current P/E ratio is -8.2.
What is the 52-week high for PCVX stock?
The 52-week high for Vaxcyte is $64.79. The current close of $58.90 is 9.1% below that high.
What is the 52-week low for PCVX stock?
The 52-week low for Vaxcyte is $30.81. The current close of $58.90 is 91.2% above that low.
Does PCVX stock pay dividends?
Vaxcyte does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for PCVX?
Vaxcyte's Debt / Equity ratio is 0.04.